Our study suggests that TNF-α directly regulates the expression of IL-33 in carcinoma cells, thus supporting the conclusion that TNF-α plays a role in immune suppression in PDA that can be overcome through blockade of bone marrow–derived macrophages in concert with immune therapy. The gene discussed is TNF; the disease is carcinoma.